Surgery Partners Inc
(NAS:SGRY)
$
27.83
2.09 (8.12%)
Market Cap: 3.54 Bil
Enterprise Value: 6.25 Bil
PE Ratio: 9,999.00
PB Ratio: 1.80
GF Score: 77/100 - Q1 2024 Surgery Partners Inc Earnings Call TranscriptMay 07, 2024$27.77 (+8.48%)Earnings
- Q4 2023 Surgery Partners Inc Earnings Call TranscriptFeb 26, 2024$30.2 (-8.60%)Earnings
- Surgery Partners Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Surgery Partners Inc Earnings Call TranscriptNov 07, 2023$28.28 (+13.99%)Earnings
- Q2 2023 Surgery Partners Inc Earnings Call TranscriptAug 01, 2023$36.94 (-4.37%)Earnings
- Q1 2023 Surgery Partners Inc Earnings Call TranscriptMay 01, 2023$39.37 (-0.73%)Earnings
- Q4 2022 Surgery Partners Inc Earnings Call TranscriptMar 01, 2023$33.99 (+1.61%)Earnings
- Surgery Partners Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Surgery Partners Inc Earnings Call TranscriptNov 08, 2022$24.64 (-2.42%)Earnings
- Q2 2022 Surgery Partners Inc Earnings Call TranscriptAug 02, 2022$34.77 (-7.40%)Earnings
- Surgery Partners Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Surgery Partners Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Surgery Partners Inc Earnings Call TranscriptMay 03, 2022$54.91 (+7.20%)Earnings
- Q4 2021 Surgery Partners Inc Earnings Call TranscriptFeb 28, 2022$52.27 (+0.50%)Earnings
- Surgery Partners Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Surgery Partners Inc Earnings Call TranscriptNov 02, 2021$41.05 (+0.64%)Earnings
- Q2 2021 Surgery Partners Inc Earnings Call TranscriptAug 04, 2021$47.98 (-14.96%)Earnings
- Surgery Partners Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Surgery Partners Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Surgery Partners Inc Earnings Call TranscriptMay 05, 2021$50.29 (+1.82%)Earnings
- Q4 2020 Surgery Partners Inc Earnings Call TranscriptMar 10, 2021$42.04 (+3.55%)Earnings
- Surgery Partners Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Surgery Partners Inc Earnings Call TranscriptNov 04, 2020$22.96 (-5.48%)Earnings
- Q2 2020 Surgery Partners Inc Earnings Call TranscriptAug 05, 2020$19.31 (+20.69%)Earnings
- Q1 2020 Surgery Partners Inc Earnings Call TranscriptMay 11, 2020$10.82 (-1.05%)Earnings
- Q4 2019 Surgery Partners Inc Earnings Call TranscriptMar 05, 2020$12.14 (-20.55%)Earnings
- Surgery Partners Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Surgery Partners Inc Earnings Call TranscriptNov 05, 2019$10.27 (+18.05%)Earnings
- Q2 2019 Surgery Partners Inc Earnings Call TranscriptAug 07, 2019$6.57 (-0.30%)Earnings
- Surgery Partners Inc at UBS Global Healthcare Conference TranscriptMay 21, 2019
- Surgery Partners Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Surgery Partners Inc Earnings Call TranscriptMay 08, 2019$10.67 (-2.38%)Earnings
- Q4 2018 Surgery Partners Inc Earnings Call TranscriptMar 13, 2019$13.03 (+4.24%)Earnings
Surgery Partners Inc at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 05:00PM GMT
Release Date Price:
$10.43
(+2.05%)
Kevin Mark Fischbeck
BofA Merrill Lynch, Research Division - MD in Equity Research
I want to thank everyone for joining us today. It's my pleasure to introduce Surgery Partners. Surgery Partners is one of the largest providers of ambulatory surgery in the United States. Presenting today, we have Tom Cowhey, the Chief Financial Officer, who was a nice enough or foolish enough just to go right into Q&A. So we'll go right in, and I encourage anybody who has any questions in the audience to ask them. But maybe I'll kick off.
Questions & Answers
Kevin Mark Fischbeck;Thomas Francis Cowhey
BofA Merrill Lynch, Research Division - MD in Equity Research;Surgery Partners, Inc. - Executive VP, CFO & Principal Accounting Officer
You came on board and Wayne came on board. Over the last couple of years you've put a bunch of things into place. Where are you now in that process? I mean, is -- how much of the work is done? And how representative is 2019 going to be to what you guys think this business can really show long-term?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)